Allianthera (Suzhou) Biopharmaceutical Co., Ltd.

China

 
Total IP 10
Total IP Rank # 153,950
IP Activity Score 2.1/5.0    18
IP Activity Rank # 46,341

Patents

Trademarks

2 0
0 0
8 0
0
 
Last Patent 2024 - Aryl hydrocarbon receptor modula...
First Patent 2022 - Prodrugs of tapinarof

Latest Inventions, Goods, Services

2024 Invention Pyrido[3,4-d]pyrimidinone and pyrimdiine aryl hydrocarbon receptor antagonists and uses thereof. ...
Invention Sprk1 inhibitors and methods of use. Provided herein are compounds having a structure of Formula ...
Invention Cyclin-dependent kinase 12 modulators and therapeutic uses thereof. Provided herein are compounds...
2023 Invention Aryl hydrocarbon receptor agonist prodrugs and methods of use thereof. Provided herein are compou...
Invention Egfr inhibitor and application thereof. A compound having a structure of formula (I), (IA), (II) ...
2022 Invention Novel modulators of the aryl hydrocarbon receptor and methods of use thereof. Disclosed herein ar...
Invention Aryl hydrocarbon receptor modulators and their use in the treatment of diseases and disorders. D...
Invention 2-aryl or heteroaryl-3-oxo-4-carbamide-6-cyclic-dihydropyrazine aryl hydrocarbon receptor modulat...
Invention Prodrugs of tapinarof. Disclosed herein are prodrugs of tapinarof and pharmaceutical formulation...
Invention Prodrugs of tapinarof. Disclosed herein are prodrugs of tapinarof and pharmaceutical formulations...